TCL Archive Senate Committee Approves Additional $400 Million For NCI, $275 Million For FDA. May 16, 2008
TCL Archive Small Phase II Study Finds New Oral Agent May Slow Progression Of Difficult Cancer April 24, 2009
TCL Archive Approvals and Applications: European Committee Signs Off On Paxene for KS reatment March 5, 1999
TCL Archive Advisors Discuss NCI Intramural Program In Closed Session, Defend Process December 16, 1994